SC 13G: Apellis Pharmaceuticals, Inc.
Ticker: APLS · Form: SC 13G · Filed: Oct 18, 2024 · CIK: 1492422
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Apellis Pharmaceuticals, Inc..
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on October 18, 2024 regarding Apellis Pharmaceuticals, Inc. (APLS).